Literature DB >> 29890126

Renal cryoablation: Multidisciplinary, collaborative and perspective approach.

Mohamed Ismail1, Tommy Kjærgaard Nielsen2, Brunolf Lagerveld3, Julien Garnon4, David Breen5, Alexander King5, Marco van Strijen6, Francis X Keeley7.   

Abstract

Renal cryoablation is becoming an established treatment option for small renal masses. It allows preservation of renal function without compromising cancer control. The technique has evolved considerably since it was first reported using liquid nitrogen over 20 years ago. We describe the modern technique for both laparoscopic and image guided renal cryoablation. Renal cryoablation is performed either laparoscopically or percutaneously depending on tumour characteristics. Common features include biopsy of the mass, protection of adjacent organs, and the use of compressed argon gas for freezing and helium for thawing. Dynamic monitoring is used to ensure adequate treatment. The shape of the iceball can be modified by adding extra needles or changing their positions. A double freeze/thaw is necessary for confident ablation of all cancer cells. The laparoscopic approach includes exposure of the tumour and may involve extensive mobilisation of the kidney. Laparoscopic ultrasound is essential for correct localisation of the tumour, needle placement, and monitoring the treatment. A Temperature probe is placed at the edge of the tumour to record treatment temperature. The percutaneous approach is typically performed with CT guidance. Adjacent organs can be protected by injecting saline or carbon dioxide. Early imaging is helpful to detect or rule out incomplete treatment. Post-operative follow-up is structured at specific intervals (e.g. 3, 6, 12 months then annually) and perhaps tailored or modified based on the degree of suspicion of inadequate treatment.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29890126     DOI: 10.1016/j.cryobiol.2018.06.002

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  4 in total

1.  Five New Cases of Primary Renal Carcinoid Tumor: Case Reports and Literature Review.

Authors:  Joel E Rosenberg; Jacob A Albersheim; Niranjan J Sathianathen; Paari Murugan; Christopher J Weight
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

Review 2.  Cryoablation versus Partial Nephrectomy for Clinical Stage T1 Renal Masses: A Systematic Review and Meta-Analysis.

Authors:  Wen Deng; Luyao Chen; Yibing Wang; Xiaoqiang Liu; Gongxian Wang; Weipeng Liu; Cheng Zhang; Xiaochen Zhou; Yu Li; Bin Fu
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

3.  Preclinical cerebral cryoablation in non-tumor bearing pigs.

Authors:  Irena Jankovic; Frantz Rom Poulsen; Christian Bonde Pedersen; Bjarne Winther Kristensen; Tine Schytte; Thomas Lund Andersen; Louise Langhorn; Ole Graumann; Willy Krone; Poul Flemming Høilund-Carlsen; Bo Halle
Journal:  Sci Rep       Date:  2022-02-07       Impact factor: 4.379

4.  Tumor-Specific Immunoenhancing Effects after Local Cryoablation for Metastatic Bone Tumor in a Mouse Model.

Authors:  Ryohei Annen; Satoshi Kato; Satoru Demura; Shinji Miwa; Akira Yokka; Kazuya Shinmura; Noriaki Yokogawa; Noritaka Yonezawa; Motoya Kobayashi; Yuki Kurokawa; Toshifumi Gabata; Hiroyuki Tsuchiya
Journal:  Int J Mol Sci       Date:  2022-08-21       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.